EDGAR Filing Documents for 0001437749-16-037081

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001437749-16-037081

Filing Date

2016-08-11

Accepted

2016-08-11 08:02:58

Documents

Period of Report

2016-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	snbp20160630_10q.htm	10-Q	551434
2	EXHIBIT 2.1	ex2-1.htm	EX-2.1	38921
3	EXHIBIT 3.1	ex3-1.htm	EX-3.1	42106
4	EXHIBIT 3.2	ex3-2.htm	EX-3.2	92653
5	EXHIBIT 10.4	ex10-4.htm	EX-10.4	50906
6	EXHIBIT 10.5	ex10-5.htm	EX-10.5	52525
7	EXHIBIT 31.1	ex31-1.htm	EX-31.1	14828
8	EXHIBIT 31.2	ex31-2.htm	EX-31.2	14792
9	EXHIBIT 32.1	ex32-1.htm	EX-32.1	5850
10	EXHIBIT 32.2	ex32-2.htm	EX-32.2	6245
	Complete submission text file	0001437749-16-037081.txt		2604181

Data Files

Seq	Description	Document	Type	Size
11	EXHIBIT 101.INS	snbp-20160630.xml	EX-101.INS	306906
12	EXHIBIT 101.SCH	snbp-20160630.xsd	EX-101.SCH	28474
13	EXHIBIT 101.CAL	snbp-20160630_cal.xml	EX-101.CAL	22803
14	EXHIBIT 101.DEF	snbp-20160630_def.xml	EX-101.DEF	191288
15	EXHIBIT 101.LAB	snbp-20160630_lab.xml	EX-101.LAB	152281
16	EXHIBIT 101.PRE	snbp-20160630_pre.xml	EX-101.PRE	205029

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387

Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196

Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)